Liver adenomatosis:: Reappraisal, diagnosis, and surgical management -: Eight new cases and review of the literature

被引:124
作者
Chiche, L
Dao, T
Salamé, E
Galais, MP
Bouvard, N
Schmutz, G
Rousselot, P
Bioulac-Sage, P
Ségol, P
Gignoux, M
机构
[1] Univ Hosp Caen, Dept Hepatobillary Surg, Caen, France
[2] Univ Hosp Caen, Dept Hepatogastroenterol, Caen, France
[3] Univ Hosp Caen, Dept Radiol, Caen, France
[4] Univ Hosp Caen, Dept Histopathol, Caen, France
[5] Univ Hosp Bordeaux, Dept Histopathol, Bordeaux, France
关键词
D O I
10.1097/00000658-200001000-00011
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective Liver adenomatosis (LA) is a rare disease originally defined by Flejou et al in 1985 from a series of 13 cases. In 1998, 38 cases were available for analysis, including eight personal cases. The aim of this study was to review and reappraise the characteristics of this rare liver disease and to discuss diagnosis and therapeutic options. Background LA was defined as the presence of >10 adenomas in an otherwise normal parenchyma. Neither female predominance nor a relation with estrogen/progesterone intake has been noted. Natural progression is poorly known. Methods The clinical presentation, evolution, histologic characteristics, and therapeutic options and results were analyzed based on a personal series of eight new cases and an updated review of the literature. Results From a diagnostic standpoint, two forms of liver adenomatosis with different presentations and evolution can be defined: a massive form and a multifocal form. The role of estrogen and progesterone is reevaluated. The risks of hemorrhage and malignant transformation are of major concern. In the authors' series, liver transplantation was indicated in two young women with the massive, aggressive form, and good results were obtained. Conclusion Liver adenomatosis is a rare disease, more common in women, where outcome and evolution vary and are exacerbated by estrogen intake. Most often, conservative surgery is indicated. Liver transplantation is indicated only in highly symptomatic and aggressive forms of the disease.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 26 条
  • [1] Hepatic adenomatosis
    Arsenault, TM
    Johnson, CD
    Gorman, B
    Burgart, LJ
    [J]. MAYO CLINIC PROCEEDINGS, 1996, 71 (05) : 478 - 480
  • [2] BERTRAND G, 1975, NOUV PRESSE MED, V4, P2276
  • [3] BISSON A, 1974, NOUV PRESSE MED, V3, P2079
  • [4] MULTIPLE HEPATOCELLULAR TUMORS IN A PATIENT TREATED WITH ORAL-CONTRACEPTIVES
    BRANDER, WL
    VOSNIDES, G
    OGG, CS
    WEST, IE
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1976, 370 (01) : 69 - 76
  • [5] BROPHY CM, 1989, AM J GASTROENTEROL, V84, P429
  • [6] BULHER H, 1982, GASTROENTEROLOGY, V82, P534
  • [7] CAQUET R, 1976, NOUV PRESSE MED, V5, P1474
  • [8] CHEN KTK, 1983, ARCH PATHOL LAB MED, V107, P274
  • [9] MR FINDINGS IN LIVER ADENOMATOSIS
    CHOI, BI
    HAN, JK
    KIM, SH
    HAN, MC
    [J]. GASTROINTESTINAL RADIOLOGY, 1991, 16 (03): : 234 - 236
  • [10] LIVER-CELL ADENOMAS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVES
    EDMONDSON, HA
    HENDERSON, B
    BENTON, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (09) : 470 - 472